Globus Medical (GMED) Tops Q4 EPS by 7c, FY Guidance Falls Short of Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Globus Medical Reports Fourth Quarter and Full Year 2020 Results
February 17, 2021 4:15 PM ESTAUDUBON, Pa., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2020.
Fourth Quarter 2020:
Worldwide net sales were $233.4 million, an increase of 10.3% as compared to the fourth quarter of 2019GAAP net income for the quarter was $53.0 million, or 22.7% of net salesGAAP diluted earnings per share (EPS) was $0.52 and non-GAAP diluted... More